J&J Q1 profit falls 10 pct. despite higher sales PDF  | Print |  E-mail
Written by Associated Press   
Tuesday, 16 April 2013 08:26

NEW BRUNSWICK, N.J. (AP) — Johnson & Johnson says its first-quarter profit fell by just over 10 percent as increased sales were offset by higher costs for production, marketing and administration.

The maker of Tylenol, prescription drugs and medical devices says it earned $3.5 billion, or $1.22 per share, down 10.6 percent from $3.9 billion, or $1.41 per share, a year earlier.

Excluding litigation and acquisition-related charges totaling $610 million, income would have been $4.1 billion, or $1.44 per share. That beat analysts' forecast by 4 cents per share.

Revenue totaled $17.5 billion, up 8.5 percent from $16.1 billion a year earlier. Analysts expected sales of $17.46 billion.

U.S. sales were up 11.2 percent as the company returned more of its recalled nonprescription drugs to store shelves. International sales grew by 6.3 percent.


Copyright 2013 The Associated Press.

 

Front Page Stories

Body of BGSU student found
07/23/2014 | Sentinel-Tribune Staff
article thumbnail

A missing poster for Cory Barron, is posted on a light pole along West 6th Street in Cle [ ... ]


Chinese lanterns may have ignited fire
07/23/2014 | PETER KUEBECK, Sentinel Staff Writer
article thumbnail

File photo. A firefighter is seen near a fire engulfing a pallet yard on West Broadway S [ ... ]


Other Front Page Articles